儿童颅咽管瘤进展评估:增强与非增强MRI比较
本研究比较儿童颅咽管瘤使用非增强MRI与增强MRI评估肿瘤进展的差异。以增强MRI为参考标准,评估基于肿瘤体积变化。结果非增强MRI对进展检测敏感度为89.9%,特异度91.4%,总体诊断准确性高,但在体积增加25–40%及小体积肿瘤中可能漏诊。
要点
- 无肿瘤体积增加或无残留病灶时,可考虑免用增强MRI
- 肿瘤体积增加25–40%或初始体积≤0.8 cm³时,建议使用增强MRI
- 评估时需覆盖全颅以排查手术通道转移植入灶,并要求高图像质量
核心结论
- 对于无体积增加或无可测量残留的颅咽管瘤,增强MRI可省略,非增强MRI显示高诊断准确性。
- 非增强MRI在体积增加25–40%的灰区及初始体积≤0.8 cm³的肿瘤中诊断性能下降,推荐使用增强MRI。
研究设计与样本
- 研究对象为儿童颅咽管瘤患者,以增强MRI为参考标准,非增强MRI基于体积变化评估进展性疾病。
- 研究比较非增强序列与增强序列对肿瘤进展检测的差异。
关键影像表现/征象
- 多数患者中,非增强T1和T2加权序列足以评估进展性疾病。
- 非增强MRI在细微肿瘤进展检测上存在局限,尤其在体积增加25–40%范围内可能出现假阴性。
- 颅咽管瘤沿手术或介入通道的转移植入灶在增强扫描后未显示进展检测改善。
诊断标准与关键数值
- 非增强MRI检测进展的敏感度为89.9%,特异度为91.4%。
- 非增强MRI阳性预测值未校正为0.90,模型推演为0.99;阴性预测值未校正为0.90,模型推演为0.99。
- 体积增加超过25%阈值时可能出现假阴性,尤其25–40%区间。
- 初始体积≤0.8 cm³的肿瘤进展可能被漏检。
临床应用与阅片要点
- 阅片时快速确认有无体积增加或可测量残留,若均无,可向临床建议免用增强。
- 体积变化处于25–40%灰区或初始病灶≤0.8 cm³时,应主动推荐增强MRI复核。
- 阅片范围需包括全颅,排查手术或介入通道的颅咽管瘤转移种植灶。
- 应用非增强MRI评估进展时,须确保扫描具备高诊断图像质量。
局限性
- 非增强MRI对细微进展和小体积肿瘤存在检出局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Standard assessment of treatment response in craniopharyngioma (CP) includes volumetric measurement of solid and cystic tumour components on contrast-enhanced MRI. This study compared the detection of tumour progression using MRI with and without contrast administration.
METHODS: Progressive disease (PD) was assessed based on the measurement of tumour volume change using MRI without contrast. Contrast-enhanced MRI served as the reference standard.
RESULTS: In most patients, non-contrast T1- and T2-weighted sequences were sufficient to assess PD. Non-contrast MRI showed a sensitivity of 89.9%, specificity of 91.4%, positive predictive value of 0.90 (unadjusted; model-derived: 0.99), and negative predictive value of 0.90 (unadjusted; model-derived: 0.99). No improvement in the detection of PD based on CP metastatic implants along the surgical/interventional pathway was seen after contrast in our cohort. There were limitations in the detection of subtle tumour progression on non-contrast MRIs. In cases of a volume increase above the 25% threshold, particularly in the > 25-40% range, false-negative results may occur. Tumour progression with small initial volumes (≤ 0.8 cm³) may also be overlooked.
CONCLUSIONS: For CPs without volume increase or no detectable or measurable tumour residue, contrast administration may be omitted. Non-contrast MRI demonstrated high diagnostic accuracy. However, performance decreased in cases with 25-40% volume increase (grey zone), where contrast-enhanced MRI is recommended, as well as for CPs with a small tumour volume (≤ 0.8 cm³). The entire skull must be evaluated to rule out CP metastatic implants; high diagnostic image quality is required.
引用
- Porto, Bison, Karakas, et al. Assessment of paediatric craniopharyngioma progression: a comparison of contrast-enhanced and non-contrast MRI. Neuroradiology. 2026. PMID: 42678532. doi:10.1007/s00234-026-04154-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。